ASRS
CRSP icon

Arizona State Retirement System’s CRISPR Therapeutics CRSP Stock Holding History

Arizona State Retirement System’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.12M Buy
23,559
+882
+4% +$46.5K 0.01% 1028
2025
Q4 		$1.19M Sell
22,677
-1,590
-7% -$95.2K 0.01% 1021
2025
Q3 		$1.57M Buy
24,267
+394
+2% +$22.6K 0.01% 913
2025
Q2 		$1.16M Buy
23,873
+656
+3% +$25.4K 0.01% 1026
2025
Q1 		$790K Sell
23,217
-251
-1% -$10.6K 0.01% 1181
2024
Q4 		$924K Buy
23,468
+239
+1% +$11.3K 0.01% 1144
2024
Q3 		$1.09M Buy
23,229
+650
+3% +$33K 0.01% 1055
2024
Q2 		$1.22M Buy
22,579
+1,841
+9% +$106K 0.01% 942
2024
Q1 		$1.41M Sell
20,738
-351
-2% -$25.1K 0.01% 874
2023
Q4 		$1.32M Sell
21,089
-262
-1% -$14.5K 0.01% 889
2023
Q3 		$969K Buy
21,351
+365
+2% +$18.9K 0.01% 1011
2023
Q2 		$1.18M Sell
20,986
-565
-3% -$32.1K 0.01% 928
2023
Q1 		$975K Buy
21,551
+640
+3% +$31.1K 0.01% 1023
2022
Q4 		$850K Buy
20,911
+915
+5% +$48.5K 0.01% 1067
2022
Q3 		$1.31M Buy
19,996
+120
+0.6% +$8.7K 0.01% 790
2022
Q2 		$1.21M Buy
19,876
+3,327
+20% +$196K 0.01% 861
2022
Q1 		$1.04M Buy
16,549
+142
+0.9% +$8.92K 0.01% 1049
2021
Q4 		$1.24M Sell
16,407
-104
-0.6% -$9.09K 0.01% 975
2021
Q3 		$1.85M Buy
16,511
+108
+0.7% +$13.6K 0.02% 752
2021
Q2 		$2.65M Sell
16,403
-810
-5% -$98.5K 0.02% 615
2021
Q1 		$2.1M Buy
17,213
+1,951
+13% +$295K 0.02% 708
2020
Q4 		$2.34M Sell
15,262
-214
-1% -$25.3K 0.02% 620
2020
Q3 		$1.29M Buy
15,476
+6,549
+73% +$581K 0.01% 791
2020
Q2 		$656K Buy
8,927
+1,875
+27% +$110K 0.01% 977
2020
Q1 		$299K Buy
+7,052
New +$364K 0.01% 1288

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arizona State Retirement System's CRSP Position: Q1 2026 in Review

Arizona State Retirement System increased its CRISPR Therapeutics (CRSP) stake by 3.9% in Q1 2026, buying an estimated $46.5K and bringing the position to 23,559 shares worth $1.12M. The position accounts for 0.01% of the portfolio, ranked #1028.

Arizona State Retirement System first reported a position in CRSP in Q1 2020 and has held it in 25 quarters since. The position peaked at $2.65M in Q2 2021. 488 funds tracked by Wall St. Rank hold CRSP as of Q1 2026.

  • Arizona State Retirement System held 23,559 shares of CRISPR Therapeutics worth $1.12M as of Q1 2026.
  • Arizona State Retirement System bought 882 CRISPR Therapeutics shares in Q1 2026, an estimated $46.5K.
  • CRISPR Therapeutics made up 0.01% of Arizona State Retirement System's portfolio in Q1 2026, its #1028 holding.
  • Arizona State Retirement System first reported a position in CRISPR Therapeutics in Q1 2020 and has held it in 25 quarters since.
  • Arizona State Retirement System's CRISPR Therapeutics position peaked at $2.65M in Q2 2021.
  • 488 funds tracked by Wall St. Rank held CRISPR Therapeutics as of Q1 2026.

Based on Arizona State Retirement System's 13F filing for Q1 2026, filed 1 May 2026.